
Twenty-year experience with SPECT/CT in nuclear medicine
Author(s) -
P.O. Korol,
Mykola Tkachenko Prof.,
О. В. Щербіна
Publication year - 2020
Publication title -
radiation diagnostics, radiation therapy
Language(s) - English
Resource type - Journals
eISSN - 2707-0700
pISSN - 2707-0697
DOI - 10.37336/2707-07800-2020-1-3
Subject(s) - single photon emission computed tomography , medical physics , nuclear medicine , computed tomography , emission computed tomography , medicine , modality (human–computer interaction) , tomography , radiology , positron emission tomography , computer science , artificial intelligence
The review discusses the results of twenty years of experience using single-photon emission computed tomography/computed tomography (SPECT/CT). Hybrid imaging, including the use of SPECT in combination with CT, translates molecular and metabolic information directly onto the clinical effect of a wide range of diseases. At the same time, SPECT/CT further improve the diagnostic accuracy, specificity and positive prognostic value of nuclear medicine research. It was considered expedient to carry out a review of modern SPECT/CT applications, not only from the perspective of a diagnostic tool, but to integrate this modality into the clinical process. To this end, complex technological issues are being resolved for attracting new radiopharmaceuticals to use SPECT/CT, improving the quality of protocols for obtaining diagnostic images, quantifying them, as well as compiling protocols for dosimetry and radiation exposure that are beyond the scope of the current review.Key words: single-photon emission computed tomography, hybrid imaging, nuclear medicine, radiopharmaceutical.